Vita 34 AG

Interim Report • Aug 27, 2025

INTERIM REPORT H1 2025

January to June 2025

GROUP KEY FIGURES

		04/01/2025 – 06/30/2025	04/01/2024 – 06/30/2024 adjusted*	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024 adjusted*
Income statement
Sales revenues	EUR thousand	21,490	19,473	43,577	38,029
Gross profit	EUR thousand	8,938	7,422	17,854	14,610
EBITDA from continuing operations	EUR thousand	1,838	1,703	4,977	3,653
EBITDA margin from continuing operations as a percentage of sales	%	8.6	8.7	11.4	9.6
Operating result (EBIT)	EUR thousand	–245	–556	776	–817
Result for the period from continuing operations	EUR thousand	802	–1,229	550	–1,443
Result for the period from discontinued operations	EUR thousand	–225	–516	–633	–924
Earnings per share from continuing operations	EUR	0.05	–0.07	0.03	–0.08
Earnings per share from discontinued operations	EUR	–0.01	–0.02	–0.03	–0.04
Balance sheet				06/30/2025	12/31/2024
Balance sheet total	EUR thousand			157,417	152,737
Equity	EUR thousand			11,771	12,907
Equity ratio	%			7.5	8.5
Liquid funds	EUR thousand			10,783	16,823
Cash flow				01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024
Cash flow from investing activities	EUR thousand			–6,340	–1,740
Depreciation and amortization	EUR thousand			4,211	4,470
Cash flow from operating activities	EUR thousand			248	4,315

* Comparative figures in the income statement adjusted in accordance with IFRS 5.34

CONTENT

Letter from the Management Board

FamiCord AG Shares

Interim Group Management Report

• Business Report
• Opportunity and Risk Report
• Forecast Report

Condensed Interim Consolidated Financial Statements

• Consolidated Income Statement
• Consolidated Statement of Comprehensive Income
• Consolidated Balance Sheet
• Consolidated Statement of Changes in Equity
• Consolidated Cash Flow Statement
• Notes to the Condensed Interim Consolidated Financial Statements
• Responsibility Statement
• Financial Calendar 2025
• Imprint

AN UNSERE AKTIONÄRE

Letter from the Management Board

LETTER FROM THE MANAGEMENT BOARD

DEAR SHAREHOLDERS,

In the first half of 2025, FamiCord AG has reinforced its turnaround, continued its positive growth track and set important strategic milestones for the future – despite continuous challenging market conditions. Although the overall economic environment in Europe, particularly in Germany, remains marked by uncertainty and birthrates remain at softer levels, we achieved significant growth in our core business and further strengthened our marketleading position in cord blood banking across Europe.

Consolidated revenues increased by 14.6% year-on-year to EUR 43.6 million (H1 2024: EUR 38.0 million). EBITDA from continuing operations rose significantly by 36.2% to EUR 5.0 million (H1 2024: EUR 3.7 million), primarily due to strong contributions from our core business and our continued focus on cost optimization. The EBITDA margin improved to 11.4% (H1 2024: 9.6%). Net profit from continuing operations turned positive to EUR 0.55 million (H1 2024: EUR –1.44 million), marking an important milestone in realigning the Group on financial strength.

As in the first quarter, a positive trend in contract structures continued: demand for subscription models is rising again, while the share of prepaid contracts is returning to the long-term average levels. At first glance, this appears to be a burden on our cash flow. However, it actually supports the future financial strength of our business model. Yes, the increase in subscription contracts was a main driver for a lower operating cash flow of EUR 0.25 million (H1 2024: EUR 4.3 million) but be mainly attributed to market shift towards recurring revenues which helps in building on our future.

The positive business trends in our Eastern European markets continued with demand for our services remaining strong. Same applies to the GCC region. In the Central European markets, however, we continue to see a mixed picture. While some markets show an overall satisfying development, some markets still lack growth momentum. But the most important message here is, that stabilization of demand continues and we can now say, that successfully managed to stop further market deterioration. In some of the Southern European markets, we have, so far, not been able to break the negative market trend. So, turning the demand situation in our key markets here, will remain an important task for us in the upcoming quarters. But as much as we are dedicated to this, we are remaining confident we will ultimately be able to turn the rights key in this area.

Cash and cash equivalents decreased during the reporting period to EUR 10.8 million (December 31, 2024: EUR 16.8 million). The main reason of that drop was a combined transaction in Slovakia and the Czech Republic. Ownership stakes of our subsidiaries in these markets were increased from 26% to 95%. This allows us full consolidation of these important markets and clearly reflects our refocusing on core business. The transaction was paid in cash fully with a smaller second payment planned for the end of 2025.

As mentioned in the beginning, a central strategic step in the second quarter was the Management Board's decision to not further prioritize development of own CAR-T cell therapies but to reemphasize our core potential and promotion of stem cell therapies. We believe FamiCordTx will continue its activity being supported by current minority shareholders and potential further new investors. This ultimately means, that FamiCordTx as an entity and CAR-T as business operations as such will no longer be included in the Group EBITDA, which leads to a restatement retrospectively with effect starting from January 1, 2024.

By focusing on our core business and establishing clear strategic priorities in family stem cell banking, we are laying the foundation for profitable, sustainable growth. The positive feedback from investors in recent weeks confirms our decision.

For the second half of 2025, the Management Board expects continued positive development in the core business. Experience from recent quarters underscores that targeted, regionally differentiated sales management and strict cost control are essential. After the substantial expansion of technical infrastructure and successful rebranding to FamiCord, profitability and sustainable, profitable growth will be at the heart of all future activities.

The Management Board is convinced that a renewed focus on the core business, combined with earnings-oriented growth management and operational excellence, will return FamiCord to former levels of profitability and financial strength. Thus, we reaffirm our outlook for the fiscal year 2025, even though we expect continuous consumer uncertainty over US politics and geopolitical upheavals.

We thank all employees for their outstanding commitment as well as our customers, partners, and investors for their trust on this important journey.

Leipzig, August 2025 The Management Board of FamiCord AG

Jakub Baran CEO

Thomas Pfaadt CFO

Cornelia Wittke-Kothe CCO

Tomasz Baran CMO

FAMICORD AG SHARES

Key share data H1 2025

FamiCord AG Shares

Ticker symbol/Reuters symbol	V3V/V3VGn.DE
Securities identification number/ISIN	A0BL84/DE000A0BL849
Number of shares	17,640,104
Price on 01/02/2025*	EUR 4.22
Price on 06/30/2025*	EUR 4.48
Market capitalization on 06/30/2025*	EUR 79.0 million

* Closing prices Xetra trading system of Deutsche Börse AG

Shareholder structure as of June 30, 2025 in %

* Thereof 208,342 own shares.

Share price development H1 2025

FamiCord AG (indexed) SDAX (indexed)

RESEARCH

In the first half of 2025, FamiCord AG was covered by the independent research firm Montega. In its latest study dated May 6, 2025, the FamiCord shares were rated "Buy" with a target price of EUR 6.50.

ANNUAL GENERAL MEETING

This year's Annual General Meeting of FamiCord AG took place in virtual form on June 25, 2025. The discharge of the Management Board and Supervisory Board, the appointment of the auditor for the fiscal year 2025, the approval of the remuneration report 2024, the confirmation of the remuneration and the remuneration system for the Supervisory Board members, and the amendment of the company's purpose in the Articles of Association were all approved by a clear majority. As Florian Schuhbauer's term of office on the Supervisory Board expired at the end of the Annual General Meeting on June 25, 2025, Tobias Silberzahn was newly elected to the Supervisory Board and subsequently elected by the Supervisory Board as its Deputy Chairman. Dr. Peter Greiner took over as Chairman. The detailed voting results are available for download at https:// ir.famicord.com/annual-general-meetings/.

INTERIM GROUP MANAGEMENT REPORT

Business Report

CORPORATE STRUCTURE AND SHAREHOLDINGS

In the first half of 2025, there were several changes in the Group structure. Polski Bank Komórek Macierzystych Sp. z o.o., Poland (PBKM), a wholly owned subsidiary of FamiCord AG, acquired an additional 69% of the shares in Národní centrum pupečníkové krve s.r.o., Czech Republic (NCP), and an additional 69% of the shares in Rodinná banka perinatálnych a mezenchymálnych buniek s.r.o., Slovakia (RBPMB). PBKM thus increased its shareholdings in NCP and RBPMB from 26% to 95% in each case. The transaction was closed in June 2025.

In June 2025, the Management Board of FamiCord AG also decided to limit its involvement in the activities related to the development of own CAR-T therapies within the Group. The decision is based on the assessment that the current operations are generating losses, that the expected benefits will materialize significantly later than originally anticipated, and that the realization of these benefits would require significant additional financial resources. The activities in question are carried out entirely by FamiCordTx S.A., a company indirectly controlled by FamiCord AG through its direct subsidiary PBKM. PBKM currently holds a 75.67% stake in FamiCordTx S.A. It is planned to increase the share capital of FamiCordTx S.A. with PBKM withholding from subscribing new shares. These measures would result in a dilution of PBKM's shareholding (most likely to estimated <20%) and, consequently, in the loss of PBKM's majority shareholding in FamiCordTx S.A. PBKM and FamiCordTx S.A. are prepared to take the necessary steps without delay, subject to the terms and conditions customary for transactions of this type.

The activities of FamiCordTx S.A. are reported as discontinued operations in accordance with IFRS 5. The comparative information for the prior-year period has been adjusted accordingly. The results of FamiCordTx S.A. are presented separately in the consolidated income statement under "result from discontinued operations". The assets and liabilities of the segment are reported in the consolidated balance sheet under "assets held for sale" and "liabilities related to assets held for sale", respectively. The discontinuation of activities and the loss of the majority interest are not expected to result in a reduction in revenue but will lead to a reduction in research and development costs (within cost of sales and administrative expenses) for the Group.

BUSINESS PERFORMANCE

The business performance in the first half of 2025 was characterized by FamiCord AG continuing its growth course, confirming and further strengthening its turnaround, and making important strategic decisions for the future. At the same time, the company faced a market that continued to be characterized by strong heterogeneity and difficult conditions. Economic concerns, interest rates, inflation, and uncertainty caused by the Russia-Ukraine war continue to play a major role, with little change. There are also no signs of a recovery in birth rates. In Germany, for example, the number of births fell by 7.1% between January and May compared with the same period in 2024.1 The company's outstanding market position in Europe and the noticeable effects of various marketing measures are having a favorable impact. The positive growth trend that has been ongoing for several quarters was confirmed with renewed momentum and double-digit revenue growth. Encouraging developments were also achieved at almost all earnings levels.

¹ https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Geburten/geburten-aktuell.html

As in the first quarter, the positive trend in contract structures continued. Demand for subscription models rose again, while the proportion of prepayment contracts returned to its long-term average level. Although these developments are having a dampening effect on cash flow in the short term, they are expected to strengthen financial power in the medium term. The increase in subscription contracts was a major reason for the lower operating cash flow in the reporting period. At the same time, however, the shift toward subscription models increases the stability and predictability of recurring revenues. In addition, fewer prepayment contracts were renewed, as these had already been concluded in bundles in the previous year, in some cases retroactively. Accordingly, fewer customer contracts were up for renewal in the current period.

Although the overall economic environment in Europe, particularly in Germany, remains uncertain and birth rates remain low or are declining in some cases, FamiCord achieved significant growth in its core business. This enabled the company to further expand its marketleading position in the umbilical cord blood banking sector in Europe. The positive business development in the Eastern European markets continued. Noticeable growth momentum is already evident here again, driven by the introduction of the placenta banking option in Poland and Romania. The same applies to the Gulf region. However, the picture in the Central European markets remains mixed. While some markets performed satisfactorily overall, others still lack growth momentum. On a positive note, overall demand continued to stabilize. In the German market, FamiCord achieved slight organic growth for the first time after a prolonged period, although the development does not yet show a steady trend. In some Southern European markets, the negative market trend has not yet been broken. Improving the demand situation in these key markets therefore remains a key task.

RESULTS OF OPERATIONS

FIRST HALF OF 2025

In the first half of 2025, the FamiCord Group generated revenue of EUR 43.6 million. This corresponds to growth of 14.6% compared with the same period of the previous year, in which EUR 38.0 million was generated. Very strong growth momentum was achieved in both quarters of the first half of the year. The absolute revenue growth of EUR 5.5 million in the first half of the year is largely attributable to the encouraging development of new business, particularly subscription contracts. In addition, there was a higher revenue contribution from prepayment contracts concluded in previous periods, which are now recognized as revenue after offsetting against contract liabilities. Price growth, additionally driven by the introduction of new products (placenta banking), also contributed to the increase in revenue. Growth was slightly dampened by slightly lower inventory revenues, as some contract extensions for contracts expiring in 2025 were successfully concluded in 2024. In the end customer business (B2C), the net amount of invoiced services rose by 4.4% year-on-year to EUR 1.6 million. The amount of annually recurring payments of EUR 11.6 million exceeded the previous year's figure by 5.5%.

The increase in cost of sales was limited to 9.8% in the first half of 2025, significantly below sales growth. The general rise in prices for materials and services and higher personnel expenses had a particularly upward effect. Thanks to the limited increase in costs, the cost of sales ratio declined. Gross profit improved from EUR 14.6 million to EUR 17.9 million, an increase of 22.2%. The effects of price adjustments and contract extensions, as well as cost discipline, had an almost entirely positive impact on earnings development. Marketing and selling expenses amounted to EUR 5.9 million in the first half of 2025, only slightly above the previous year's level of EUR 5.5 million. Despite the continuing challenging market environment, marketing and sales activities were deliberately maintained at a comparable level, which was made possible in part by the expansion of the sales team. At the same time, marketing and sales budgets were and are being adjusted regionally, depending on the situation in the respective country markets. Administrative expenses also increased significantly less than proportionately, from EUR 9.9 million to EUR 10.9 million. This includes legal fees related to M&A and, as in the previous year, corresponding limited expenses for activities in the CDMO area. Expenses for cell and gene therapies (including CAR-T) were adjusted in the two reporting periods 2024 and 2025 in line with the decision not to continue these activities.

The dynamic revenue growth, combined with continued cost discipline, ensured that EBITDA from continuing operations rose disproportionately from EUR 3.7 million to EUR 5.0 million. This development corresponds to an increase of 36.2%. The EBITDA margin from continuing operations climbed from 9.6% to 11.4%. EBIT improved significantly in the first half of 2025, from EUR –0.8 million to EUR +0.8 million, returning to positive territory in both quarters of 2025.

Similar to the same period of the previous year, an even more positive EBIT development was prevented by impairments on financial assets and contract assets amounting to EUR 0.6 million (previous year: EUR 0.9 million) as a result of poorer payment behavior among private customers in the wake of the economic downturn. The financial result for the first six months of 2025 improved from EUR –0.6 million in the previous year to EUR +0.5 million. This includes hyperinflation accounting in both periods, which was triggered by the inflationary environment for the subsidiary in Turkey and had an even greater impact in the previous year. The adjusted fair value of the existing minority interest in the companies in the Czech Republic and Slovakia, which are now majorityowned, had a positive effect in the reporting period.

FamiCord also returned to profitability in the first half of 2025 in terms of result for the period from continuing operations. After a loss of EUR 1.4 million in the previous year, a profit of EUR 0.6 million was now achieved. With a result for the period from discontinued operations of EUR –0.6 million (previous year: EUR –0.9 million), the total result was EUR –0.1 million (previous year: EUR –2.4 million). Based on the six-month period, this corresponds to (undiluted) earnings per share from continuing operations of EUR 0.03 (previous year: EUR –0.08).

SECOND QUARTER OF 2025

The second quarter of 2025 essentially confirmed the developments that already characterized the course of business in the first quarter, with momentum remaining high. At EUR 21.5 million, revenue was on par with the first three months of the year (EUR 22.1 million) and, with an increase of 10.4%, was significantly higher than the EUR 19.5 million reported in the same quarter of the previous year. EBITDA from continuing operations for the second quarter of 2025 amounted to EUR 1.8 million, up 8.0% on the same quarter of the previous year (EUR 1.7 million). The EBITDA margin from continuing operations was 8.6%, compared with 8.7% in the previous year. The overall positive earnings trend of the first quarter thus continued.

Marketing and sales activities remained at a high level in the second quarter of 2025, and FamiCord continued to invest in expanding its sales teams. EBIT for the second quarter of 2025 was EUR –0.2 million, roughly on par with the previous year's figure of EUR –0.6 million. The result for the period from continuing operations increased significantly from EUR –1.2 million to EUR +0.8 million compared to the previous quarter. This was positively influenced by the significantly improved financial result and by income tax income.

DEVELOPMENT IN THE SEGMENTS

In the subgroup PBKM segment, revenue increased by 19.0% from EUR 29.4 million to EUR 35.0 million in the first half of 2025. In the months from April to June, growth was 14.2%, from EUR 15.1 million to EUR 17.2 million. This means that strong momentum was generated in both quarters, seamlessly continuing the previous year's development. The cost of sales ratio, which is usually higher in the subgroup PBKM in a segment comparison, was further improved. This is also reflected in the segment's EBITDA from continuing operations, which rose by 47.0% from EUR 4.1 million to EUR 6.1 million in the first half of 2025. In the second quarter, EBITDA from continuing operations increased by 19.6% from EUR 2.2 million to EUR 2.6 million. Investments in the subgroup PBKM amounted to EUR 6.2 million in the first six months of 2025 (previous year: EUR 0.9 million) and were mainly used to acquire majority interests in the Czech Republic and Slovakia and to purchase cryogenic tanks.

In the subgroup Vita 34, revenues remained stable at EUR 9.2 million in the first half of 2025 (previous year: EUR 9.2 million). Revenue in the second quarter of 2025 was slightly below the prior-year quarter's level of EUR 4.7 million at EUR 4.5 million. Slightly weaker-thanexpected demand for new contracts was offset by positive price effects, the sale of more extensive service packages, and growth in contract renewals. Overall, the trend appears to have stabilized, particularly in Germany. The segment's EBITDA for the first six months of 2025 was EUR –1.1 million, compared with EUR –0.5 million in the same period of the previous year. In the second quarter of 2025, EBITDA amounted to EUR –0.8 million, compared with EUR –0.5 million in the same quarter of the previous year. Investments continued to be implemented in a very controlled manner and, due to interest payments received, amounted to a net cash inflow of EUR 0.5 million in the first half of 2025, compared with a cash outflow of EUR 0.6 million in the same period of 2024.

FINANCIAL POSITION

The solid revenue and earnings performance is also reflected in the development of operating cash flow. However, the change in the contract structure toward more annual payment contracts is leading to a significant slowdown in current cash inflows, with a simultaneous shift in cash inflows to the future. This can be seen in the increase in contract assets. At the same time, contract liabilities grew less sharply than in the previous year – an indication of slightly lower cash flow from contract renewals with prepayments. As an increasing proportion of the contract portfolio is due for renewal in the coming years, this trend is expected to reverse. Overall, cash flow from operating activities decreased from EUR 4.3 million to EUR 0.2 million in the first half of 2025. The prior-year period was marked by a favorable development in income tax expense due to a tax refund received – an effect that was expected to be one-time in nature and did not recur in 2025. Depreciation and amortization remained virtually stable at EUR 4.2 million (prior-year period: EUR 4.5 million).

The FamiCord Group invested a net total of around EUR 6.3 million in the reporting period. In the previous year, this figure was significantly lower at EUR 1.7 million. Investments in property, plant, and equipment, particularly in cryogenic tanks and laboratory equipment, accounted for EUR 2.0 million. Another important area of investment was the acquisition of majority stakes in subsidiaries in the Czech Republic and Slovakia.

Financing activities resulted in a cash inflow of EUR 0.8 million, compared with an outflow of EUR 5.4 million in the same period of the previous year. While FamiCord mainly repaid bank loans as planned in the previous year without taking on any new debt, additional financial loans as part of the investment loan and the overdraft facility were utilized in 2025. As of June 30, 2025, the FamiCord Group had cash and cash equivalents of EUR 10.8 million, compared to EUR 14.4 million as of December 31, 2024. The change is mainly due to the acquisitions, which were paid for in cash. In addition, the item "assets held for sale" includes cash and cash equivalents from discontinued operations amounting to EUR 0.4 million.

NET ASSETS

Compared to December 31, 2024, the ratio of non-current to current assets and their absolute values as of June 30, 2025, showed a shift toward non-current assets. The main reason for this is the majority acquisitions in the Czech Republic and Slovakia, which were reflected in particular in a corresponding increase in goodwill. Depreciation and investments in property, plant, and equipment amounted to EUR 26.3 million (December 31, 2024: EUR 24.8 million), resulting in a slight increase. Investments in cryogenic tanks in Poland were the main factor here. Total depreciation and amortization for the period on property, plant, and equipment and intangible assets amounted to EUR 4.2 million, compared with EUR 4.5 million, and was in line with the long-term depreciation and amortization plan. Non-current contract assets rose significantly again by EUR 3.5 million or 20.1% from EUR 17.3 million to EUR 20.7 million. Contract extensions had an upward effect here. As a result of these factors, non-current assets grew by 6.7% or EUR 7.5 million from EUR 112.2 million to EUR 119.7 million.

By contrast, current assets declined by a total of EUR 2.8 million to EUR 37.7 million. This was due to several, partly offsetting effects. Trade receivables increased from EUR 13.7 million to EUR 15.6 million in line with the higher business volume. Current contract assets recorded a slight increase due to maturities. By contrast, other non-financial assets declined as a result of lower prepaid services for the storage of cell deposits. Assets held for sale related to the discontinued CAR-T operations were recognized in the amount EUR 1.1 million as of June 30, 2025 following the decision to discontinue this area of business. As there is no requirement to retrospectively restate the data in the balance sheet, assets related to discontinued operations are presented as originally recognized in the respective lines. The main factor behind the decline in current assets was liquidity, which fell from EUR 16.8 million to EUR 10.8 million due to the cash payments made for the majority acquisitions.

Equity remained relatively stable at EUR 11.8 million, compared with EUR 12.9 million as of December 31, 2024. With the balance sheet total increasing at the same time, this results in an equity ratio of 7.5%, compared with 8.5%. The slight absolute decline in equity was due to currency effects, which were reflected in other reserves. Non-current liabilities were slightly higher at EUR 87.3 million than at the end of 2024, when they stood at EUR 84.7 million. Current liabilities increased from EUR 55.2 million to EUR 58.3 million. This was due to increased utilization of interest-bearing loans within the investment credit line and the overdraft facility. All other current items remained virtually unchanged. Contract liabilities increased slightly, both in the noncurrent and current areas, in particular due to contract extensions and a slightly higher volume of contracts with short-term maturities or pending extensions that are structured as prepayment contracts. The largest items in current liabilities remained repayment obligations of EUR 26.3 million (December 31, 2024: EUR 27.0 million), which are of theoretical nature because they comprise potential repayment claims by customers. These items, which dominate the liabilities side of the balance sheet, dilute the Group's equity base. Since they are of a theoretical nature (repayment obligations) on the one hand and are more an indication of the success of the Group's business model (contract liabilities due to prepayments) on the other, this should be taken into account in the analysis of the equity ratio.

Opportunity and Risk Report

The detailed opportunity and risk report is included in the Annual Report 2024 (p. 35 ff.). It also addresses the risk of providing the necessary funds for the subsidiary FamiCordTx. This financing risk is expected to become less significant with the decision to discontinue this business segment.

There were no significant changes in other opportunities and risks during the reporting period compared with the combined management report for 2024.

Forecast Report

The forecast for 2025 given in the consolidated financial statements 2024 is confirmed. FamiCord continues to expect a challenging year in 2025 due to the economic situation in Europe and heterogeneous developments in individual country markets. For the year as a whole, consolidated revenue in the range of EUR 85 to 95 million and EBITDA in the range of EUR 8.7 to 10.3 million are expected. The discontinuation of activities related to the development of CAR-T therapies within the Group has no impact on the forecast. The majority acquisitions of the companies in the Czech Republic and Slovakia completed on June 30, 2025, should be reflected in revenue and earnings particularly from 2026 onwards. Thanks to its long-standing market position, continued dynamic business development, and solid financing structures, the Group remains well positioned in terms of financing. With its budget 2025 and further planning for 2026, FamiCord is continuing its consistent earningsand liquidity-oriented business policy. At the same time, the initiatives launched in 2024 are expected to continue to provide additional growth momentum in the current fiscal year. The business development in the first half of the year is already clear evidence of the positive effects.

The number of new storages across the Group as a whole is expected to be moderately above the figure 2024 in 2025. Despite the difficult market environment and possible fluctuations during the year, further organic growth is planned in terms of new customer contracts and the number of storages for 2025 as a whole. FamiCord continues to see excellent opportunities for further growth in market acceptance of its own products and services. These opportunities are to be exploited through appropriate marketing and sales activities, which will be continued at a higher level overall in 2025 than in 2024. Capital expenditure will be significantly below the level 2024 and will be managed in line with requirements.

The forecast is based on a stable exchange rate of the euro against the Polish zloty and other currencies (HUF, RON, TRY, GBP, AED, CHF). Effects from further acquisitions, including potential transaction costs resulting therefrom, are not included in the forecast.

FORWARD-LOOKING STATEMENTS

This half-year financial report contains forward-looking statements. They are based on the information available to the Group at the time the report was prepared. However, such forward-looking statements are subject to risks and uncertainties. If the underlying assumptions do not materialize or if further opportunities/risks arise, actual results may differ from the estimates provided. Therefore, FamiCord cannot guarantee these statements.

Leipzig, August 27, 2025 The Management Board of FamiCord AG

Jakub Baran CEO

Thomas Pfaadt CFO

Cornelia Wittke-Kothe CCO

Tomasz Baran CMO

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

Consolidated Income Statement

Sales revenues 21,490 19,473 43,577 38,029 Cost of sales –12,551 –12,051 –25,723 –23,419 Gross profit on sales 8,938 7,422 17,854 14,610 Other income 215 782 685 1,295 Marketing and selling expenses –2,986 –2,852 –5,864 –5,457 Administrative expenses –6,141 –5,268 –10,948 –9,866 Other expenses –33 –303 –371 –467 Net impairment on financial and contract assets –239 –337 –580 –933 Operating result (EBIT) –245 –556 776 –817 Financial income 1,255 849 1,800 1,229 Financial expenses –379 –1,026 –1,261 –1,747 Earnings before taxes 632 –733 1,315 –1,335 Income tax expense/income 170 –496 –765 –108 Result for the period from continuing operations 802 –1,229 550 –1,443 Result for the period from discontinued operations –225 –516 –633 –924 Total result after taxes 576 –1,745 –83 –2,367 Attribution of the result for the period from continuing operations to the Owners of the parent company 831 –1,148 551 –1,460 Minority interests –30 –81 –1 17 Attribution of the result for the period from discontinued operations to the Owners of the parent company –171 –392 –481 –703 Minority interests –54 –124 –152 –222 Attribution of the total result to the Owners of the parent company 660 –1,540 69 –2,162 Minority interests –84 –205 –153 –205 Earnings per share, undiluted/diluted (EUR) Undiluted and diluted, relating to the result for the period attributable to holders of ordinary shares of the parent company 0.04 –0.09 0.00 –0.12 Earnings per share from continuing operations 0.05 –0.07 0.03 –0.08 Earnings per share from discontinued operations –0.01 –0.02 –0.03 –0.04	EUR thousand	04/01/2025 – 06/30/2025	04/01/2024 – 06/30/2024 adjusted*	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024 adjusted*

* Comparative figures adjusted in accordance with IFRS 5.34 (see note 2.2 for explanation)

Consolidated Statement of Comprehensive Income

EUR thousand	04/01/2025 – 06/30/2025	04/01/2024 – 06/30/2024	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024
Result for the period	576	–1,745	–83	–2,367
Other comprehensive income
Currency translation differences	–1,694	346	–1,144	1,652
Other comprehensive income to be reclassified to the income statement in subsequent periods	–1,694	346	–1,144	1,652
Total comprehensive income after taxes	–1,118	–1,399	–1,227	–715
Attribution of the comprehensive income after taxes to
Owners of the parent company	–1,088	–1,318	–1,079	–491
Non-controlling interests	–30	–81	–149	–223

Consolidated Balance Sheet

Assets

EUR thousand	06/30/2025	12/31/2024
Non-current assets
Goodwill	35,199	30,664
Other intangible assets	12,194	13,549
Property, plant and equipment	26,301	24,808
Right-of-use assets	10,843	11,577
Shares in associated companies	0	747
Other financial assets	1,209	888
Other non-financial assets	1,731	1,766
Deferred tax assets	11,223	10,655
Contract assets	20,745	17,275
Trade receivables	243	278
	119,688	112,207
Current assets
Inventories	3,107	2,933
Trade receivables	15,581	13,698
Income tax receivables	306	220
Contract assets	4,220	3,726
Other financial assets	721	1,641
Other non-financial assets	1,935	1,489
Assets held for sale	1,077	0
Cash and cash equivalents	10,783	16,823
	37,728	40,530

Total assets	157,417	152,737

Konzern-Balance sheet

(Passiva)

Consolidated Balance Sheet

Equity & liabilities

EUR thousand	06/30/2025	12/31/2024
Equity
Subscribed capital	17,640	17,640
Capital reserve	42,354	42,354
Loss carryforwards	–42,300	–42,292
Other reserves	–1,732	–755
Treasury shares	–2,813	–2,813
Non-controlling interests	–1,378	–1,228
	11,771	12,907
Non-current liabilities
Interest-bearing loans	3,697	3,751
Lease liabilities	8,364	9,251
Deferred grants	602	625
Contract liabilities	67,389	65,019
Other provisions	476	424
Deferred tax liabilities	6,727	5,600
Other non-financial liabilities	44	0
	87,299	84,669
Current liabilities
Trade payables	6,477	6,478
Other provisions	5	5
Income tax liabilities	117	150
Interest-bearing loans	4,503	1,970
Lease liabilities	3,106	3,125
Deferred grants	136	143
Repayment obligations	26,271	27,015
Contract liabilities	10,878	10,012
Other financial liabilities	1,413	1,624
Other non-financial liabilities	5,287	4,641
Liabilities related to assets held for sale	155	0
	58,348	55,161

Total equity & liabilities	157,417	152,737

Total equity

Consolidated Statement of Changes in Equity

Subscribed capital	Capital reserves	Loss carryforwards	Reserve for financial assets measured at fair value through other comprehensive income
17,640	42,354	–31,329	–24
0	0	–2,198	0
0	0	0	0
0	0	–2,198	0
0	–1,248	1,248	0
0	0	63	0
0	0	0	0
0	0	0	0
17,640	41,106	–32,215	–24
17,640	42,354	–42,292	–24
0	0	–101	0
0	0	0	0
0	0	–101	0
0	0	93	0
0	0	0	0
17,640	42,354	–42,300	–24
			Equity attributable to the owners of the parent company

Consolidated Statement of Changes in Equity

Equity attributable to the owners of the parent company Reserve for financial assets measured at fair value through other Currency comprehensive Revaluation translation Total Treasury shares at Non-controlling Total income reserves differences equity acquisition cost interests equity –24 –122 –2,145 26,375 –2,813 –786 22,776 0 0 0 –2,198 0 –169 –2,367 0 0 1,652 1,652 0 –54 1,598 0 0 1,652 –545 0 –223 –769 0 0 0 0 0 0 0 0 0 0 63 0 0 63 0 0 0 0 0 –2 –2 0 0 0 0 0 0 0 –24 –122 –492 25,893 –2,813 –1,012 22,067 –24 –122 –609 16,947 –2,813 –1,228 12,907 0 0 0 –101 0 18 –83 0 0 –978 –978 0 –166 –1,144 0 0 –978 –1,079 0 –149 –1,227 0 0 0 93 0 0 93 0 0 0 0 0 –2 –2
–24	11,771	–1,378	–2,813	15,962	–1,586	–122

Consolidated Cash Flow Statement

EUR thousand	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024*
Cash flow from operating activities
Result for the period before income taxes	1,315	–2,259
Result for the period from discontinued operations	–633
Adjustments for:
Depreciation and amortization	4,211	4,470
Gains/losses on the disposal	–296	–9
Other non-cash expenses	–1,271	–266
Financial income	–1,800	–1,240
Financial expenses	1,261	1,764
Changes in net working capital
+/- Inventories	–193	–133
+/- Receivables and other assets	26	–534
+/- Contract assets	–3,965	–2,991
-/+ Debts	–561	–887
-/+ Contract and repayment liabilities	2,658	5,805
-/+ Provisions	52	5
Interest paid	–359	–616
Income taxes paid/received	–195	1,207
Cash flow from operating activities	248	4,315
Cash flow from investing activities
Purchase of intangible assets	–241	–836
Purchase of property, plant and equipment	–2,042	–829
Acquisition of companies, net of cash and cash equivalents	–3,984	0
Purchase of non-current financial investments	–93	–83
Proceeds from the sale of property, plant and equipment	1	1
Proceeds from the sale of financial investments	13	0
Interest received	5	7
Cash flow from investing activities	–6,340	–1,740
Cash flow from financing activities
Dividend distributions	–2	–2
Proceeds from taking out financial loans	3,443	176
Payments for the repayment of financial loans	–995	–3,921
Payments for leases	–1,656	–1,602
Cash flow from financing activities	790	–5,350
Net changes in cash and cash equivalents	–5,302	–2,775
Cash and cash equivalents at the beginning of the reporting period	16,823	17,416
Exchange rate-related change in cash and cash equivalents	–326	–197
Cash and cash equivalents of assets held for sale	413	0
Cash and cash equivalents at the end of the reporting period	10,783	14,443

* The previous year's figures have not been adjusted in the cash flow statement. Information on cash flows from discontinued operations is presented in the notes.

Notes to the Condensed Interim Consolidated Financial Statements as of June 30, 2025

1. INFORMATION ON THE PARENT COMPANY AND THE GROUP

The unaudited condensed interim consolidated financial statements of FamiCord AG comprise FamiCord AG and its subsidiaries (together referred to as "FamiCord" or "Group").

FamiCord AG (the "Company") is based in Leipzig (Germany), Perlickstraße 5, and is registered in the commercial register of the Leipzig Local Court under number HRB 20339. The object of the Company and its subsidiaries is the collection, storage, and distribution of cells, tissues, blood, and blood components for medical applications. In addition, the Group develops products and pharmaceuticals based on these materials, including the production of viral vectors as well as CAR-T cells or comparable products. Further activities include the storage and cryopreservation of sperm and oocytes for use in reproductive medicine, research, and development in these areas, as well as the manufacturing and distribution of medical devices and comparable products.

The interim consolidated financial statements of the Group for the period from January 1 to June 30, 2025, were approved for publication by the Management Board on August 27, 2025.

2. ACCOUNTING AND VALUATION PRINCIPLES

2.1 BASIS OF PREPARATION OF THE FINANCIAL STATEMENTS

The condensed interim consolidated financial statements for the period from January 1 to June 30, 2025, have been prepared in accordance with IAS 34 "Interim Financial Reporting".

The condensed interim consolidated financial statements do not contain all the disclosures and information required for the financial statements for the fiscal year and should be read in conjunction with the consolidated financial statements as of December 31, 2024.

Furthermore, various standards and amendments to standards were applied for the first time in 2025, which have no impact on the consolidated financial statements of FamiCord AG. The Group has not early adopted any standards, amendments or interpretations that have been published but are not yet effective.

2.2 DISCONTINUED OPERATIONS

In June 2025, FamiCord AG decided to discontinue activities related to the development of CAR-T therapies within the Group, as the current operations are generating losses, the expected benefits are significantly further in the future than originally anticipated, and significant additional financing would be required.

These activities are carried out entirely by FamiCordTx S.A., a company indirectly controlled by FamiCord AG through its direct subsidiary Polski Bank Komórek Macierzystych Sp. z o.o. (PBKM), which holds a 75.67% stake in FamiCordTx S.A.

It is planned to increase the share capital of FamiCordTx S.A. with PBKM withholding from subscribing new shares. This would result in a dilution of PBKM's shareholding and, consequently, in the loss of PBKM's majority shareholding in FamiCordTx S.A.

PBKM and FamiCordTx S.A. are prepared to take the necessary steps without delay, subject to the terms and conditions customary for transactions of this type.

The impact on the net assets, results of operations, and financial position of FamiCordTx S.A. is presented below:

EUR thousand	04/01/2025 – 06/30/2025	04/01/2024 – 06/30/2024	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024
Sales revenues	0	0	0	1
Cost of sales	–127	–291	–315	–519
Gross profit on sales	–127	–291	–315	–517
Other income	0	33	0	33
Administrative expenses	–90	–257	–311	–434
Operating result (EBIT)	–216	–515	–626	–918
Financial income	0	7	1	10
Financial expenses	–9	–8	–8	–17
Earnings before taxes	–225	–516	–633	–924
Result from discontinued operations	–225	–516	–633	–924

The main groups of assets and liabilities of FamiCordTx S.A. classified as held for sale in the meaning of IFRS 5 as of June 30, 2025, are as follows:

EUR thousand	06/30/2025
Assets
Intangible assets	471
Property, plant, and equipment	48
Other financial receivables and assets	25
Other non-financial receivables and assets	120
Cash and cash equivalents	413
Assets held for sale	1,077
Liabilities
Trade payables	16
Other financial liabilities	14
Other non-financial liabilities	126
Liabilities directly related to assets held for sale	155

The net cash flows generated by FamiCordTx S.A. are as follows:

EUR thousand	01/01/2025 – 06/30/2025	01/01/2024 – 06/30/2024
Cash flow from operating activities	–552	–776
Cash flow from investing activities	0	–430
Cash flow from financing activities	0	0
Exchange rate-related change in cash and cash equivalents	10	0
Net change in cash	–543	–1,205

3. KEY ESTIMATES AND ASSUMPTIONS

In preparing these interim financial statements, Management has made discretionary decisions and estimates that affect the application of accounting principles and the reporting of net assets, financial position, and results of operations. Actual results may differ from these estimates. The key discretionary decisions made by Management in applying the Group's accounting and valuation methods and the most important sources of estimation uncertainties are the same as those described in the last consolidated financial statements.

4. HYPERINFLATION

Turkey is classified as a hyperinflationary economy and therefore IAS 29 "Financial Reporting in Hyperinflationary Economies" applies to our subsidiaries in Turkey. Accordingly, the interim financial statements of the companies that have the Turkish lira as their functional currency have been adjusted retroactively from January 1, 2022, to reflect the change in general purchasing power. For translation into the presentation currency (euro), all amounts are translated at the exchange rate prevailing on June 30, 2025.

To reflect changes in purchasing power on the balance sheet date, the carrying amounts of non-monetary assets and liabilities, equity and comprehensive income of subsidiaries in high-inflation economies are adjusted on the basis of a measuring unit applicable on the balance sheet date. These are indexed using a general price index in accordance with IAS 29. However, no adjustment is required for monetary assets and liabilities that are reported at the amounts applicable on the balance sheet date, such as net realizable value or fair value, as well as for monetary items, as they represent cash held, receivable or payable. All items in the income statement must be stated in the measurement unit applicable on the balance sheet date.

Non-monetary assets that have been adjusted in accordance with the guidance in IAS 29 remain subject to impairment testing in accordance with the guidance in the relevant IFRSs.

The application of IAS 29 is immaterial for the profitability, liquidity, capital resources, and financial position of the Group for the first half of the year ended June 30, 2025. The table below shows the specific factors that were used to apply IAS 29 for the first six months ended June 30, 2025.

Consumer price index	Tüketici fiyat endeks rakamları
Index as of June 30, 2023	1,351.59
Index as of December 31, 2023	1,859.38
Index as of June 30, 2024	2,319.29
Index as of December 31, 2024	2,684.55
Index as of June 30, 2025	3,132.17

The effects on the individual items of the consolidated balance sheet and consolidated income statement are as follows:

EUR thousands	06/30/2025	12/31/2024
Non-current assets	573	636
Goodwill	257	278
Intangible assets	14	17
Property, plant, and equipment	302	341
Current assets	23	28
Inventories	23	28
Equity	–98	–13
Retained earnings	–36	–12
Other reserves	–62	–1
Short-term liabilities	12	–618
Contract liabilities	104	–484
Other liabilities	–92	–135
Income statement	H1 2025	H1 2024
Result	–634	–222
Sales revenues	–141	–112
Cost of sales	109	126
Financial income	–602	–235

5. SEGMENT REPORTING

5.1 SEGMENT RESULTS

The FamiCord Group reports on the two segments subgroup Vita 34 and subgroup PBKM.

The results of operations of the segments for the first half of 2025 are as follows:

H1 2025 EUR thousand	Subgroup Vita 34	Subgroup PBKM	Total	Consolidation	Group
Segment sales revenues	9,184	34,981	44,165	–588	43,577
Cost of sales	–4,755	–21,370	–26,125	403	–25,722
Marketing and selling expenses	–3,542	–2,444	–5,986	123	–5,863
Administrative expenses	–3,631	–7,478	–11,109	161	–10,948
Depreciation, amortization, and impairment losses	–1,526	–2,675	–4,201	0	–4,201
EBITDA	–1,109	6,085	4,976	1	4,977
Earnings before taxes	–2,499	3,503	1,004	311	1,315

H1 2024 EUR thousand	Subgroup Vita 34	Subgroup PBKM	Total	Consolidation	Group
Segment sales revenues	9,188	29,393	38,581	–552	38,029
Cost of sales	–4,742	–19,175	–23,917	498	–23,419
Marketing and selling expenses	–3,193	–2,319	–5,513	56	–5,457
Administrative expenses	–3,672	–6,307	–9,978	112	–9,866
Depreciation, amortization, and impairment losses	–1,526	–2,944	–4,470	0	–4,470
EBITDA	–508	4,138	3,630	23	3,653
Earnings before taxes	–2,053	680	–1,373	38	–1,335

The earnings situation of the segments for the first half of 2024 is as follows:

Due to the classification of FamiCordTx S.A. as a discontinued operation in accordance with IFRS 5, the comparative information for the first half of 2024 has been adjusted accordingly. The income and expenses of the discontinued operation are no longer reported in the continuing operations but are presented separately as "discontinued operations" (see explanations in section 2.2).

The differences between the totals from both subsegments and the figures for the Group as a whole are entirely attributable to the consolidation of expenses and income as well as the consolidation of equity.

5.2 INFORMATION ON GEOGRAPHICAL AREAS

The Group generates its sales revenues of EUR 12,310 thousand (previous year: EUR 11,253 thousand) in Poland, EUR 7,682 thousand (previous year: EUR 7,245 thousand) in Germany and EUR 6,692 thousand (previous year: EUR 4,103 thousand) in Switzerland. The remaining sales of EUR 16,893 thousand (previous year: EUR 15,429 thousand) were generated in other countries.

The Group's non-current assets are broken down as follows:

EUR thousand	06/30/2025	12/31/2024
Domestic	21,006	21,581
Poland	31,745	33,854
Switzerland	11,476	9,140
Portugal	7,667	8,541
Other foreign countries	25,890	26,187
Group	97,783	99,303

Non-current assets are allocated according to the registered office of the individual Group company.

6. SALES REVENUES FROM CONTRACTS WITH CUSTOMERS

The sales revenues reported in the income statement for continuing operations are broken down by type of service provided as follows:

EUR thousand	H1 2025	H1 2024
Sales from processing/manufacturing	28,938	23,833
Sales from storage	12,283	12,034
Other sales	2,356	2,163
	43,577	38,030

a.Income taxes

The Group calculates its periodic income tax expense using the tax rate that would be applicable to the expected total annual result. The income tax expense is composed as follows:

EUR thousand	H1 2025	H1 2024
Actual income tax expense	–173	–145
Deferred income tax expense	–592	37
	–765	–108

7. FINANCIAL ASSETS AND FINANCIAL LIABILITIES

The carrying amounts of financial assets and financial liabilities are presented in the following tables. The carrying amount corresponds to the fair value.

EUR thousands	06/30/2025	12/31/2024
Financial assets
Financial assets at amortized cost
Trade receivables	15,827	13,976
Other financial assets	1,587	2,182
	17,414	16,158
Financial assets measured at fair value through profit or loss
Other financial assets	116	121
Financial assets measured at fair value through other comprehensive income
Other financial assets	158	157
Total financial assets	17,688	16,436
Financial liabilities
Financial liabilities at amortized cost
Interest-bearing loans	8,200	5,720
Trade payables	6,477	6,478
Other financial liabilities	1,413	1,624
	16,090	13,823
Total financial liabilities	16,090	13,823

Current trade receivables, other financial receivables, trade payables and other financial liabilities generally have short remaining terms. The amounts reported in the balance sheet approximate their fair values.

The fair values of non-current trade receivables with remaining terms of more than one year correspond to the present values of the payments associated with the assets using a market interest rate. They are classified in level 3 of the fair value hierarchy.

Financial assets that are measured at fair value through profit or loss or at fair value through other comprehensive income are classified in level 2 of the fair value hierarchy. The fair value of the loans granted to third parties reported under other financial assets as of December 31, 2024, did not differ significantly from the carrying amount.

The fair values of long-term loans and lease liabilities, which are measured at amortized cost in the balance sheet, were determined by discounting the expected future cash flows using market interest rates. They were classified in level 3 of the fair value hierarchy.

The fair values of assets reported under other financial assets are determined using appropriate valuation methods, with classification also being made in level 3 of the fair value hierarchy.

8. CHANGES IN THE SCOPE OF CONSOLIDATION

On May 28, 2025, PBKM, a wholly owned subsidiary of FamiCord AG, has entered into an agreement with Primecell Advanced Therapy, a.s., Czech Republic, (Primecell) to acquire a further 69% of the shares in Národní centrum pupečníkové krve s.r.o., Czech Republic (NCP), as well as a further 69% of the shares in Rodinná banka perinatálnych a mezenchymálnych buniek s.r.o., Slovakia (RBPMB).

PBKM thereby increased its stake in NCP and respectively in RBPMB from 26% to 95%. With a 5% shareholding, Primecell remains a shareholder and strategic partner of both entities. PBKM has an option to acquire these remaining 5% of shares as well for a pre-agreed fixed price.

NCP and RBPMB. are family stem cell banks focused on the collection, testing, processing and storage of cord blood and cord tissue of newborns. Both companies offer services similar to other companies of FamiCord Group.

The conditions precedent to the closing have been fulfilled as of June 16, 2025. The acquisition has been accounted for as of June 30, 2025, and, consequently, the companies' results will be included in the consolidated financial statements starting from July 1, 2025.

As of June 30, 2025, the Group had not completed the purchase price allocation (PPA) process. The allocation presented below is preliminary. The Company is in the process of identifying and measuring the acquired assets and liabilities in faire values.

Prior to obtaining control, the Group held a 26% equity interest in both entities. In accordance with IFRS 3 "Business Combinations", the previously held equity interest was remeasured to its fair value at the acquisition date. The preliminary remeasurement resulted in the recognition of a gain of EUR 512 thousand, which was recognized in financial income. The fair value of the previously held interest at the acquisition date has been included in the calculation of goodwill arising from the business combination.

Non-controlling interests in the acquired companies as of the acquisition date amounted to EUR 51 thousand and were attributable to a 5% ownership interest. The value of the non-controlling interests was measured proportionally to the net assets of the companies.

The preliminary fair value of the companies' identifiable assets and liabilities as of the acquisition date was as follows:

Národní centrum pupečníkové krve s.r.o. (Czech Republic)	Preliminary values at the acquisition date (CZK)	Preliminary values at the acquisition date (EUR)
Acquired assets
Intangible assets (non-current)	154,672	6,253
Property, plant, and equipment (non-current)	2,828,991	114,376
Inventories	466,247	18,850
Current receivables	9,543,770	385,855
Cash on hand and cash equivalents	6,448,521	260,714
Other assets	4,843,190	195,810
Total assets	24,285,390	981,858
Assumed liabilities
Trade payables	1,820,123	73,588
Non-current provisions	324,017	13,100
Other liabilities	460,657	18,624
Total liabilities	2,604,797	105,312
Net asset value	21,680,593	876,546
Acquired shares	69.00%	69.00%
Shares already held	26.00%	26.00%
Purchase price 69%	94,652,669	3,826,807
Fair value of the 26% share already held	24,966,356	1,009,390
Minority interests	6,720,984	271,729
Goodwill at acquisition date	99,022,462	4,003,478

FamiCord Interim Report H1 2025 Condensed Interim Consolidated Financial Statements

Notes to the Condensed Interim Consolidated Financial Statements as of June 30, 2025

Rodinná banka perinatálnych a mezenchymálnych buniek s.r.o. (Slovak Republic)	Preliminary values at the acquisition date (EUR)
Acquired assets
Current receivables	124,002
Cash and cash equivalents	78,009
Other assets	898
Total assets	202,910
Assumed liabilities
Trade payables	50,318
Other liabilities	4,275
Total liabilities	54,593
Net asset value	148,317
Acquired shares	69.00%
Shares already held	26.00%
Purchase price 69%	959,323
Fair value of the 26% share already held	253,039
Minority interests	45,978
Goodwill at acquisition date	1,071,460

9. DISCLOSURES ON RELATIONSHIPS WITH RELATED COMPANIES AND PERSONS

Related companies or persons are defined as associated companies and joint ventures (including their subsidiaries) and non-consolidated subsidiaries, as well as persons who exercise significant influence over the financial and business policies of FamiCord. The latter include all persons in key positions and their close family members. At FamiCord, these are the members of the Management Board and the Supervisory Board.

There were no significant events or business transactions in the period from January 1 to June 30, 2025.

10. EVENTS AFTER THE BALANCE SHEET DATE

In August 2023, FamiCord AG, as sole shareholder, decided to liquidate Vita 34 Slovakia s.r.o., based in Bratislava, Slovakia. The relevant shareholder resolutions have been passed, the liquidator appointed, and all preparatory measures completed. The company has yet to be deleted from the commercial register, but this is expected to happen soon. Due to its minor economic significance, the company was not included in the consolidated financial statements in the past. The transaction therefore has no material impact on the Group's net assets, financial position, and results of operations.

On August 11, 2025, the notarial purchase agreement for the acquisition of Eticur GmbH, a sub-subsidiary of FamiCord AG, was signed by PBKM. The economic transfer of the company is scheduled for October 1, 2025. The transaction has no material impact on the Group's net assets, financial position, or results of operations.

No other reportable events occurred after the reporting date of June 30, 2025.

Leipzig, August 27, 2025 The Management Board of FamiCord AG

Jakub Baran CEO

Thomas Pfaadt

CFO

Cornelia Wittke-Kothe CCO

Tomasz Baran CMO

RESPONSIBILITY STATEMENT

To the best of our knowledge, we assure that, in accordance with the applicable accounting principles for interim financial reporting, the interim consolidated financial statements give a true and fair view of the Group's net assets, financial position and results of operations, and that the business performance, including the business result, and the position of the Group are presented in the interim group management report in such a way that a true and fair view is given, and that the principal opportunities and risks associated with the expected development of the Group in the remaining fiscal year are described.

Leipzig, August 27, 2025 The Management Board of FamiCord AG

Jakub Baran CEO

Thomas Pfaadt CFO

Cornelia Wittke-Kothe CCO

Tomasz Baran CMO

FINANCIAL CALENDAR 2025

11/21/2025 Quarterly Statement (Q3)

IMPRINT

CONTACT

FamiCord AG Perlickstraße 5 04103 Leipzig Germany

Telephone: +49 (0)341 48792-48 Telefax: +49 (0)341 48792-39 E-mail: ir@famicord.com

EDITORIAL TEAM

FamiCord AG, Leipzig Better Orange IR & HV AG, Munich

CONCEPT & DESIGN

Silvester Group, Hamburg

PHOTO CREDITS FamiCord AG, Leipzig

NOTE

In the interests of readability, this interim report does not use the masculine, feminine and diverse (m/f/d) forms of language simultaneously. All references to persons apply equally to all genders.

PUBLICATION

This interim report was published on August 27, 2025, in German and English and can be downloaded from our website. In case of deviations, only the German version is authoritative.

FamiCord on the Internet: www.famicord.com

FamiCord AG

Perlickstraße 5 | D–04103 Leipzig | Germany T: +49 (0)341 48792-48 | F: +49 (0)341 48792-39 ir@famicord.com | www.famicord.com